If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Flora Peyvandi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles
Hemophilia A Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Mutation Medicine & Life Sciences
Thrombotic Thrombocytopenic Purpura Medicine & Life Sciences
von Willebrand Factor Medicine & Life Sciences
Genes Medicine & Life Sciences
Afibrinogenemia Medicine & Life Sciences
Factor VIII Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

2 Citations (Scopus)

Advances in the treatment of hemophilia: Implications for laboratory testing

Tripodi, A., Chantarangkul, V., Novembrino, C. & Peyvandi, F., Feb 1 2019, In : Clinical Chemistry. 65, 2, p. 254-262 9 p.

Research output: Contribution to journalReview article

Blood Coagulation Factors
Chromogenics
Hemophilia A
Assays
Testing

Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis

Weyand, A. C., Grzegorski, S. J., Rost, M. S., Lavik, K. I., Ferguson, A. C., Menegatti, M., Richter, C. E., Asselta, R., Duga, S., Peyvandi, F. & Shavit, J. A., Jun 11 2019, In : Blood advances. 3, 11, p. 1670-1680 11 p.

Research output: Contribution to journalArticle

Open Access
Factor V
Zebrafish
Factor V Deficiency
Hemostasis
Hemostatics
1 Citation (Scopus)

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease

Peyvandi, F., Castaman, G., Gresele, P., De Cristofaro, R., Schinco, P., Bertomoro, A., Morfini, M., Gamba, G., Barillari, G., Jiménez-Yuste, V., Königs, C., Iorio, A. & Federici, A. B., Sep 1 2019, In : Blood transfusion = Trasfusione del sangue. 17, 5, p. 391-398 8 p.

Research output: Contribution to journalArticle

von Willebrand Diseases
Therapeutics
Hemorrhage
Epistaxis
Type 3 Von Willebrand's Disease

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease: Blood transfusion = Trasfusione del sangue

Peyvandi, F., Castaman, G., Gresele, P., De Cristofaro, R., Schinco, P., Bertomoro, A., Morfini, M., Gamba, G., Barillari, G., Jiménez-Yuste, V., Königs, C., Iorio, A. & Federici, A. B., 2019, In : Blood Transfus. 17, 5, p. 391-398 8 p.

Research output: Contribution to journalArticle

Body mass index reduction improves the baseline procoagulant imbalance of obese subjects

Tripodi, A., Primignani, M., Badiali, S., de Ruberto, F., Granelli, P., Tosetti, G., Clerici, M., Padovan, L., Chantarangkul, V., Scalambrino, E. & Peyvandi, F., Jul 15 2019, In : Journal of Thrombosis and Thrombolysis. 48, 1, p. 52-60 9 p.

Research output: Contribution to journalArticle

Thrombin
Body Mass Index
Thrombophilia
Obesity
Thrombin Time